Literature DB >> 12623841

Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs.

Debra D Dahlen1, Virginia C Broudy, Jonathan G Drachman.   

Abstract

Receptor-mediated internalization appears to be the primary mean of regulating the plasma level of thrombopoietin (TPO). However, the processes that regulate Mpl internalization have not previously been described. Using the cytokine-dependent cell line BaF3, we have identified 2 distinct motifs within the cytoplasmic domain of Mpl that underlie ligand-dependent internalization. Removal of the fourth cytoplasmic tyrosine residue by deletion or truncation results in a significant decrease in maximal internalization. The remaining receptor internalization is abrogated by deletion of cytoplasmic residues 54-69, which include the core box2 region (L54L55E56I57L58) and the only dileucine motifs (L54L55 and I57L58) within the cytoplasmic domain of Mpl. Receptor internalization mediated by this latter subdomain does not require Jak2 activation. Furthermore, TPO-stimulated cellular proliferation appears to be directly correlated with receptor internalization, indicating that internalization of the TPO/Mpl complex may be essential for normal signal transduction. Finally, we have demonstrated that upon removal of TPO from the supernatant, Mpl promptly reappears on the cell surface, suggesting that a pool of intracellular Mpl can be rapidly recycled to the cell surface. These data help identify the receptor motifs involved in TPO-induced internalization of Mpl and suggest that Mpl translocation may be necessary for normal cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623841     DOI: 10.1182/blood-2002-11-3468

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.

Authors:  Luigi J Alvarado; Heather D Huntsman; Hai Cheng; Danielle M Townsley; Thomas Winkler; Xingmin Feng; Cynthia E Dunbar; Neal S Young; Andre Larochelle
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

Review 2.  Megakaryopoiesis.

Authors:  Amy E Geddis
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

3.  A case of hepatitis B reactivation in an anti-HBs positive, anti-HBc positive non-Hodgkin's lymphoma patient.

Authors:  Chunchen Wu; Hui Shi; Mengji Lu; Yang Xu; Xinwen Chen
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

4.  Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.

Authors:  Bin Zhang; Ling Li; Yinwei Ho; Min Li; Guido Marcucci; Wei Tong; Ravi Bhatia
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

5.  Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice.

Authors:  Markus Bender; Silvia Giannini; Renata Grozovsky; Terese Jönsson; Hilary Christensen; Fred G Pluthero; Amy Ko; Ann Mullally; Walter H A Kahr; Karin M Hoffmeister; Hervé Falet
Journal:  Blood       Date:  2014-12-02       Impact factor: 22.113

6.  A network map of thrombopoietin signaling.

Authors:  Firdous A Bhat; Jayshree Advani; Aafaque Ahmad Khan; Sonali Mohan; Arnab Pal; Harsha Gowda; Prantar Chakrabarti; T S Keshava Prasad; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2018-07-24       Impact factor: 5.782

7.  Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of congenital thrombocytopenias.

Authors:  Matthias Ballmaier; Wolfgang Holter; Manuela Germeshausen
Journal:  Haematologica       Date:  2015-04-24       Impact factor: 9.941

8.  YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation.

Authors:  Ian S Hitchcock; Maximus M Chen; Jennifer R King; Kenneth Kaushansky
Journal:  Blood       Date:  2008-05-16       Impact factor: 22.113

9.  Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor.

Authors:  Mahban I Irandoust; Lambertus H J Aarts; Onno Roovers; Judith Gits; Stefan J Erkeland; Ivo P Touw
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

10.  New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.

Authors:  Ara Metjian; Charles S Abrams
Journal:  Biologics       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.